+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B, Peginterferon Beta-1A), By Route of Administration (Intramuscular, Intravenous, Subcutaneous), Distribution Channel - Forecast 2024-2030- Product Image
Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B, Peginterferon Beta-1A), By Route of Administration (Intramuscular, Intravenous, Subcutaneous), Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B, Peginterferon Beta-1A), By Route of Administration (Intramuscular, Intravenous, Subcutaneous), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887678
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Beta Interferon Market size was estimated at USD 3.44 billion in 2023, USD 3.62 billion in 2024, and is expected to grow at a CAGR of 5.83% to reach USD 5.11 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Beta Interferon Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Beta Interferon Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Beta Interferon Market, highlighting leading vendors and their innovative profiles. These include Amega Biotech, Bayer AG, Biogen Inc., Biosidus S.A, Bristol-Myers Squibb Company, F. Hoffmann La-Roche Ltd., Faron Pharmaceuticals, Merck KGaA, Nanogen Pharmaceutical Biotechnology, Novartis Pharmaceuticals Corporation, Qiagen GmbH, Sino Biological, Inc., and Synairgen PLC.

Market Segmentation & Coverage

This research report categorizes the Beta Interferon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Interferon Beta-1A
    • Interferon Beta-1B
    • Peginterferon Beta-1A
  • By Route of Administration
    • Intramuscular
    • Intravenous
    • Subcutaneous
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Beta Interferon Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Beta Interferon Market?
  3. What are the technology trends and regulatory frameworks in the Beta Interferon Market?
  4. What is the market share of the leading vendors in the Beta Interferon Market?
  5. Which modes and strategic moves are suitable for entering the Beta Interferon Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Beta Interferon Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of autoimmune diseases among population
5.1.1.2. Growing healthcare awareness and initiatives for immune disorders
5.1.1.3. Improved healthcare infrastructure and spending across economies
5.1.2. Restraints
5.1.2.1. Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
5.1.3. Opportunities
5.1.3.1. Robust research activities to advanced individualized disease management for people living with multiple sclerosis
5.1.3.2. Development of technology-driven platforms for disease diagnosis
5.1.4. Challenges
5.1.4.1. Stringent and time consuming approval processes associated with beta interferon products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Beta Interferon Market, by Type
6.1. Introduction
6.2. Interferon Beta-1A
6.3. Interferon Beta-1B
6.4. Peginterferon Beta-1A
7. Beta Interferon Market, by By Route of Administration
7.1. Introduction
7.2. Intramuscular
7.3. Intravenous
7.4. Subcutaneous
8. Beta Interferon Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Beta Interferon Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Beta Interferon Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Beta Interferon Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amega Biotech
13.1.2. Bayer AG
13.1.3. Biogen Inc.
13.1.4. Biosidus S.A
13.1.5. Bristol-Myers Squibb Company
13.1.6. F. Hoffmann La-Roche Ltd.
13.1.7. Faron Pharmaceuticals
13.1.8. Merck KGaA
13.1.9. Nanogen Pharmaceutical Biotechnology
13.1.10. Novartis Pharmaceuticals Corporation
13.1.11. Qiagen GmbH
13.1.12. Sino Biological, Inc.
13.1.13. Synairgen PLC
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BETA INTERFERON MARKET RESEARCH PROCESS
FIGURE 2. BETA INTERFERON MARKET SIZE, 2023 VS 2030
FIGURE 3. BETA INTERFERON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BETA INTERFERON MARKET DYNAMICS
FIGURE 7. BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BETA INTERFERON MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BETA INTERFERON MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BETA INTERFERON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BETA INTERFERON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BETA INTERFERON MARKET SIZE, BY PEGINTERFERON BETA-1A, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BETA INTERFERON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BETA INTERFERON MARKET SIZE, BY BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. BETA INTERFERON MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. BETA INTERFERON MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. BETA INTERFERON MARKET LICENSE & PRICING

Companies Mentioned

  • Amega Biotech
  • Bayer AG
  • Biogen Inc.
  • Biosidus S.A
  • Bristol-Myers Squibb Company
  • F. Hoffmann La-Roche Ltd.
  • Faron Pharmaceuticals
  • Merck KGaA
  • Nanogen Pharmaceutical Biotechnology
  • Novartis Pharmaceuticals Corporation
  • Qiagen GmbH
  • Sino Biological, Inc.
  • Synairgen PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.11 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Global Interferon Market by Type (Alpha, Beta, Gamma), Category (Natural, Synthetic (Laboratory Made)), Distribution Channel, Application - Forecast 2024-2030 - Product Image

Global Interferon Market by Type (Alpha, Beta, Gamma), Category (Natural, Synthetic (Laboratory Made)), Distribution Channel, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Interferon - Global Strategic Business Report - Product Image

Interferon - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Beta Interferon - Global Strategic Business Report - Product Image

Beta Interferon - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Global Interferons Market 2024-2028 - Product Image

Global Interferons Market 2024-2028

  • Report
  • 160 Pages
  • Global
From

About the Market

Beta Interferon is a type of biotechnology drug used to treat multiple sclerosis (MS). It is a synthetic form of a naturally occurring protein that helps to reduce inflammation and slow the progression of MS. Beta Interferon is administered through injections and is used to reduce the frequency of MS relapses. It is also used to reduce the severity of symptoms and slow the progression of disability. Beta Interferon is one of the most widely used treatments for MS, and is often prescribed in combination with other therapies. It is also used to treat other neurological conditions, such as chronic inflammatory demyelinating polyneuropathy. The Beta Interferon market is highly competitive, with several major players offering a range of products. Companies in the market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.